Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Copeland

Showing results (571-580 of 573) with videos related to

Pageof 58
Sort By:
You have reached the last page of results.This site can display upto 573 results.
Journal of Medicinal Chemistry|April 28, 2010
Discovery of GSK1070916, a potent and selective inhibitor of Aurora B/C kinaseNicholas D Adams, Jerry L Adams, Joelle L Burgess, et al.
Cancer Cell|July 2, 2019
Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP LossAndrew Fedoriw, Satyajit R Rajapurkar, Shane O'Brien, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of the First Potent and Selective Inhibitor of Centromere-Associated Protein E: GSK923295Xiangping Qian, Andrew McDonald, Han-Jie Zhou, et al.
Pageof 58

Showing results (571-580 of 573) with videos related to

Sort By:
Pageof 58
You have reached the last page of results.This site can display upto 573 results.
Journal of Medicinal Chemistry|April 28, 2010
Discovery of GSK1070916, a potent and selective inhibitor of Aurora B/C kinaseNicholas D Adams, Jerry L Adams, Joelle L Burgess, et al.
Cancer Cell|July 2, 2019
Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP LossAndrew Fedoriw, Satyajit R Rajapurkar, Shane O'Brien, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of the First Potent and Selective Inhibitor of Centromere-Associated Protein E: GSK923295Xiangping Qian, Andrew McDonald, Han-Jie Zhou, et al.
Pageof 58